Exagen (XGN) Shares Outstanding (Diluted Average) (2020 - 2026)
Exagen filings provide 7 years of Shares Outstanding (Diluted Average) readings, the most recent being $23.9 million for Q1 2026.
- On a quarterly basis, Shares Outstanding (Diluted Average) rose 28.55% to $23.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was $23.9 million, a 28.55% increase, with the full-year FY2025 number at $21.6 million, up 18.43% from a year prior.
- Shares Outstanding (Diluted Average) hit $23.9 million in Q1 2026 for Exagen, up from $21.6 million in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $23.9 million in Q1 2026 to a low of $17.0 million in Q1 2022.
- Median Shares Outstanding (Diluted Average) over the past 5 years was $17.9 million (2024), compared with a mean of $18.6 million.
- Biggest five-year swings in Shares Outstanding (Diluted Average): surged 31.28% in 2022 and later rose 2.3% in 2024.
- Exagen's Shares Outstanding (Diluted Average) stood at $17.1 million in 2022, then grew by 3.5% to $17.7 million in 2023, then rose by 2.96% to $18.2 million in 2024, then grew by 18.43% to $21.6 million in 2025, then grew by 10.65% to $23.9 million in 2026.
- The last three reported values for Shares Outstanding (Diluted Average) were $23.9 million (Q1 2026), $21.6 million (Q4 2025), and $20.9 million (Q3 2025) per Business Quant data.